Toronto, Canada (PRWEB) October 25, 2012
Pediatric drug development may be thought of as more noble than adult clinical research, with investigators determined to uncover new treatment options for kids. Unfortunately, the job of investigative sites in attracting and converting patients for pediatric studies can be considerably more daunting.
Starting in the 1950s, pediatric clinical research networks were initially formed around more acute conditions such as oncology and rheumatology. Investigators recognized the power of combining resources in order to recruit the right type and quantity of patients to advance clinical research for new treatments.
Pediatric clinical research networks have flourished in the last 60 years and a wide range of specialty care, primary care and disease-specific networks exist to not only improve the coordination, speed and quality of randomized controlled trials, but in some cases to also study critical drugs to improve labeling for pediatric use.
Topics to be discussed include:
- The evolution and current landscape of pediatric clinical research networks
- Selecting and engaging with the right network for your pediatric trial
- Enhancing your pediatric clinical research process while fostering high-quality, ethical research on medicines for use in children
This webinar is part of a series on Pediatric Clinical Trials. Archives can be accessed on demand through Xtalks.
For more information or to register go to http://xtks.in/xto-539p
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com/ContactUs.ashx
Karen Lim (416) 977-6555 ext 227